{"acquisitions":[],"changes":[{"companyHref":"/c/nexotx-com","date":"2026-09-27","documentUrl":"https://www.nea.com/portfolio","domain":"nexotx.com","fact":"provenance:investor:nea","name":"Nexo Therapeutics, Inc.","new":{"publisher":"New Enterprise Associates","status":"sourced","url":"https://www.nea.com/portfolio"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"New Enterprise Associates","reason":null,"retrievedAt":"2026-09-27","slug":"nexotx-com","status":"sourced","url":"https://whoraisedwhat.com/c/nexotx-com"},{"companyHref":"/c/nexotx-com","date":"2026-09-25","documentUrl":null,"domain":"nexotx.com","fact":"latest round","name":"Nexo Therapeutics, Inc.","new":{"amountUsd":60000000,"date":"2026-03-27","lead":null,"type":null},"old":{"amountUsd":60000000,"date":"2026-03-27","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-06-07","slug":"nexotx-com","status":"attributed","url":"https://whoraisedwhat.com/c/nexotx-com"}],"country":"US","description":"Nexo Therapeutics is a drug-discovery company developing covalent medicines aimed at proteins long considered undruggable. It targets diseases driven by transcription factors, scaffolding proteins, and other targets traditional drugs cannot reach. Its covalent ligand discovery platform spans all nucleophilic amino acids and captures shallow, transient pockets that conventional approaches miss.","domain":"nexotx.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":["nea"],"lat":39.580678,"lng":-105.053118,"location":"LITTLETON, CO","multiples":[],"name":"Nexo Therapeutics, Inc.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":60000000,"connectionsAmong":[],"currency":"USD","date":"2026-03-27","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"nexotx-com-2026-03-27-round","source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-06-07","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"nexotx-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-06-07","status":"attributed","url":null},{"fact":"existence","publisher":"nexotx.com","retrievedAt":"2026-06-07","status":"self-reported","url":"https://nexotx.com"},{"fact":"description","publisher":"nexotx.com","retrievedAt":"2026-06-07","status":"self-reported","url":"https://nexotx.com"},{"fact":"investor:nea","publisher":"New Enterprise Associates","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.nea.com/portfolio"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"New Enterprise Associates\", \"role\": \"portfolio\", \"slug\": \"nea\", \"sources\": [{\"publisher\": \"New Enterprise Associates\", \"retrievedAt\": \"2026-09-27\", \"status\": \"sourced\", \"url\": \"https://www.nea.com/portfolio\"}]}","kind":"investor","sources":[{"publisher":"New Enterprise Associates","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.nea.com/portfolio"}],"text":"Nexo Therapeutics, Inc. was listed in New Enterprise Associates's portfolio, recorded 2026-09-27."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"New Enterprise Associates","role":"portfolio","slug":"nea","sources":[{"publisher":"New Enterprise Associates","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.nea.com/portfolio"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["bootstrap","carto analytics","cloudflare","http/3","jquery 3.7.1","jquery migrate 3.4.1","mysql","php 8.4.21","underscore.js","understrap","wordpress 7.0"],"totalRaisedUsd":60000000,"traction":[],"updatedAt":"2026-06-07","valuations":[]}